Former Eisai and Eli Lilly Alzheimer’s disease leader joins executive team to advance commercialization strategy for ...

HighlightsAgreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to ...

The Generic Drugs Market has emerged as one of the most critical segments of the global pharmaceutical industry due to its ...

The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...

Market OverviewThe global allergy diagnostics market is expected to witness strong growth at a compound annual growth rate of ...

The Organ Preservation Market plays a vital role in modern healthcare and transplantation medicine. Organ preservation refers ...

Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full ...

GelMEDIX Inc., a biotechnology company developing regenerative therapies to restore vision, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients ...

ST. LOUIS--(BUSINESS WIRE)--#Alzheimers--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached an agreement with BeauBrain ...

Investment-level benchmarks bring sector-level transparency to the global private equity marketBOSTON--(BUSINESS WIRE)--#HarbourVest--Global private markets investment firm HarbourVest Partners today ...

Cambridge Cognition (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, reports that ...

Over 2 million women in the UK are affected by moderate to severe hot flushes and night-sweats associated with menopause. 1,2·         Fezolinetant is the first neurokinin targeted therapy ...